Home  /  Resource Library  /  Feasibility And Efficacy Of Addition Of Individualized Dose Lenalidomide To Chlorambucil And Rituximab As First-Line Treatment In Elderly And FCR-Unfit Patients With Advanced Chronic Lymphocytic Leukemia

Feasibility And Efficacy Of Addition Of Individualized Dose Lenalidomide To Chlorambucil And Rituximab As First-Line Treatment In Elderly And FCR-Unfit Patients With Advanced Chronic Lymphocytic Leukemia

Results of a small study investigating the combination of lenalidomide, rituximab and chlorambucil for first line treatment of elderly and unfit patients with CLL.